Literature DB >> 28939212

Fortilin: A Potential Target for the Prevention and Treatment of Human Diseases.

Decha Pinkaew1, Ken Fujise2.   

Abstract

Fortilin is a highly conserved 172-amino-acid polypeptide found in the cytosol, nucleus, mitochondria, extracellular space, and circulating blood. It is a multifunctional protein that protects cells against apoptosis, promotes cell growth and cell cycle progression, binds calcium (Ca2+) and has antipathogen activities. Its role in the pathogenesis of human and animal diseases is also diverse. Fortilin facilitates the development of atherosclerosis, contributes to both systemic and pulmonary arterial hypertension, participates in the development of cancers, and worsens diabetic nephropathy. It is important for the adaptive expansion of pancreatic β-cells in response to obesity and increased insulin requirement, for the regeneration of liver after hepatectomy, and for protection of the liver against alcohol- and ER stress-induced injury. Fortilin is a viable surrogate marker for in vivo apoptosis, and it plays a key role in embryo and organ development in vertebrates. In fish and shrimp, fortilin participates in host defense against bacterial and viral pathogens. Further translational research could prove fortilin to be a viable molecular target for treatment of various human diseases including and not limited to atherosclerosis, hypertension, certain tumors, diabetes mellitus, diabetic nephropathy, hepatic injury, and aberrant immunity and host defense.
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcohol liver injury; Apoptosis; Atherosclerosis; Cancers; Development; Diabetes mellitus; Endoplasmic reticulum (ER) stress; Fortilin; HRF; Histamine-releasing factor; Host defense; Hypertension; IRE1α; Immunity; Liver regeneration; Pulmonary arterial hypertension; TCTP; TPT1; Translationally controlled tumor protein; Tumors

Mesh:

Substances:

Year:  2017        PMID: 28939212      PMCID: PMC6064975          DOI: 10.1016/bs.acc.2017.06.006

Source DB:  PubMed          Journal:  Adv Clin Chem        ISSN: 0065-2423            Impact factor:   5.394


  152 in total

1.  Mechanisms of artemisinin resistance in the rodent malaria pathogen Plasmodium yoelii.

Authors:  D J Walker; J L Pitsch; M M Peng; B L Robinson; W Peters; J Bhisutthibhan; S R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  AB5 subtilase cytotoxin inactivates the endoplasmic reticulum chaperone BiP.

Authors:  Adrienne W Paton; Travis Beddoe; Cheleste M Thorpe; James C Whisstock; Matthew C J Wilce; Jamie Rossjohn; Ursula M Talbot; James C Paton
Journal:  Nature       Date:  2006-10-05       Impact factor: 49.962

Review 3.  TCTP as therapeutic target in cancers.

Authors:  Julie Acunzo; Virginie Baylot; Alan So; Palma Rocchi
Journal:  Cancer Treat Rev       Date:  2014-03-02       Impact factor: 12.111

4.  The Plasmodium falciparum translationally controlled tumor protein: subcellular localization and calcium binding.

Authors:  J Bhisutthibhan; M A Philbert; H Fujioka; M Aikawa; S R Meshnick
Journal:  Eur J Cell Biol       Date:  1999-09       Impact factor: 4.492

5.  Characterization of fortilin, a novel antiapoptotic protein.

Authors:  F Li; D Zhang; K Fujise
Journal:  J Biol Chem       Date:  2001-10-11       Impact factor: 5.157

6.  Human recombinant histamine-releasing factor activates human eosinophils and the eosinophilic cell line, AML14-3D10.

Authors:  R Bheekha-Escura; D W MacGlashan; J M Langdon; S M MacDonald
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

7.  The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin.

Authors:  J Bhisutthibhan; X Q Pan; P A Hossler; D J Walker; C A Yowell; J Carlton; J B Dame; S R Meshnick
Journal:  J Biol Chem       Date:  1998-06-26       Impact factor: 5.157

Review 8.  Diabetes mellitus statistics on prevalence and mortality: facts and fallacies.

Authors:  Paul Zimmet; K George Alberti; Dianna J Magliano; Peter H Bennett
Journal:  Nat Rev Endocrinol       Date:  2016-07-08       Impact factor: 43.330

9.  TCTP is a critical factor in shrimp immune response to virus infection.

Authors:  Wenlin Wu; Bingyan Wu; Ting Ye; Huagen Huang; Congjie Dai; Jianjun Yuan; Wei Wang
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

10.  Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin.

Authors:  Ulrich-Axel Bommer; Kara L Vine; Prianka Puri; Martin Engel; Lisa Belfiore; Karen Fildes; Marijka Batterham; Alistair Lochhead; Morteza Aghmesheh
Journal:  Cell Commun Signal       Date:  2017-02-01       Impact factor: 5.712

View more
  7 in total

1.  Expression and purification of a cleavable recombinant fortilin from Escherichia coli for structure activity studies.

Authors:  Maranda S Cantrell; Jackson D Wall; Xinzhu Pu; Matthew Turner; Luke Woodbury; Ken Fujise; Owen M McDougal; Lisa R Warner
Journal:  Protein Expr Purif       Date:  2021-10-06       Impact factor: 1.650

Review 2.  Histamine-Releasing Factor, a New Therapeutic Target in Allergic Diseases.

Authors:  Yu Kawakami; Kazumi Kasakura; Toshiaki Kawakami
Journal:  Cells       Date:  2019-11-26       Impact factor: 7.666

Review 3.  Dysregulation of TCTP in Biological Processes and Diseases.

Authors:  Ulrich-Axel Bommer; Adam Telerman
Journal:  Cells       Date:  2020-07-07       Impact factor: 6.600

4.  High Plasma Levels of Fortilin in Patients with Coronary Artery Disease.

Authors:  Masayuki Aoyama; Yoshimi Kishimoto; Emi Saita; Reiko Ohmori; Kojiro Tanimoto; Masato Nakamura; Kazuo Kondo; Yukihiko Momiyama
Journal:  Int J Mol Sci       Date:  2022-08-10       Impact factor: 6.208

5.  Biological Activities of Glass Ionomer Cement Supplemented with Fortilin on Human Dental Pulp Stem Cells.

Authors:  Prawichaya Sangsuwan; Sissada Tannukit; Wilaiwan Chotigeat; Ureporn Kedjarune-Leggat
Journal:  J Funct Biomater       Date:  2022-08-28

Review 6.  Repurposing Drugs to Treat Heart and Brain Illness.

Authors:  Maranda S Cantrell; Alejandro Soto-Avellaneda; Jackson D Wall; Aaron D Ajeti; Brad E Morrison; Lisa R Warner; Owen M McDougal
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-16

7.  Role of TCTP in Cell Biological and Disease Processes.

Authors:  Ulrich-Axel Bommer; Toshiaki Kawakami
Journal:  Cells       Date:  2021-09-02       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.